 |
|
|
 |
|
Study Finds Potential Cause of Age-Related Macular Degeneration
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 | 3 Indeed, the authors tested that theory directly, by injecting Slit2 protein into the eyes of mouse models of AMD and diabetic retinopathy. In both cases, Slit2 reduced the angiogenesis that is a hallmark of disease.
But Williams noted that this same approach would not likely be viable therapeutically. Instead, a Slit2 molecular agonist (that is, a molecular mimic) would need to be developed and tested in humans -- a process that could take a decade or more before arriving in the clinic, he said.
AMD is the leading cause of blindness in Americans over the age of 55, according to the American Macular Degeneration Association, affecting more than 10 million individuals.
Text Continues Below

More information
For more on diseases of the eye, visit the U.S. National Eye Institute.
Page: << Prev | 1 | 2 | 3
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 3/17/2008
|
 |

SOURCES: Dean Y. Li, M.D., Ph.D., H. A. and Edna Benning Presidential Endowed Chair in Medicine, University of Utah, Salt Lake City; George A. Williams, M.D., chairman, Department of Opthalmology, William Beaumont Hospital, Royal Oak, Mich.; March 16, 2008, Nature Medicine, online
|